NCT01731353 FungiScope - A Global Emerging Fungal Infection Registry
| NCT ID | NCT01731353 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cologne |
| Condition | Invasive Fungal Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2003-03 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2003-03 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.
Eligibility Criteria
Inclusion Criteria: * Cultural, histopathological, antigen or DNA evidence of invasive fungal infection Exclusion Criteria: * Infection due to Candida spp., Cryptococcus neoformans, Pneumocystis jiroveci * Endemic fungal infection such as coccidioidomycosis or histoplasmosis * Colonisation or other non-invasive infection
Contact & Investigator
Oliver A. Cornely, Professor
PRINCIPAL INVESTIGATOR
University Hospital of Cologne
Frequently Asked Questions
Who can join the NCT01731353 clinical trial?
This trial is open to participants of all sexes, studying Invasive Fungal Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01731353 currently recruiting?
Yes, NCT01731353 is actively recruiting participants. Contact the research team at oliver.cornely@uk-koeln.de for enrollment information.
Where is the NCT01731353 trial being conducted?
This trial is being conducted at Cologne, Germany.
Who is sponsoring the NCT01731353 clinical trial?
NCT01731353 is sponsored by University of Cologne. The principal investigator is Oliver A. Cornely, Professor at University Hospital of Cologne. The trial plans to enroll 1,000 participants.